August 05, 2022CorporateRika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First DonorTerumo Blood and Cell Technologies’ new Rika system represents a new era in plasma collections
August 02, 2022FinancialNotification Regarding Status of Acquisition of the Company's Own Shares (PDF 104.39 KB) (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation)
August 02, 2022CorporateTerumo Announces Regulatory Approval of Drug-Device Combination Product Co-Developed with Kyowa KirinExpected to Reduce the Burden on Patients Receiving Chemotherapy
Investors Japanese Financial Results for the First Quarter of Fiscal Year Ending March 31, 2023 August 9, 2022 IR Library Audio Webcast Stock Quote Prime Market of TSE: Last Trade JPY Change JPY (%) Volume View Chart Top Management Message Shinjiro Sato, President and CEO 5-Year Growth Strategy 2022 - 2026 Terumo Report Sustainability What's New August 12, 2022 Q&A regarding Financial Results for the First Quarter of FYE 3/2023 August 10, 2022 Audio webcast regarding Financial Results for FYE 3/2023 August 09, 2022 Presentation regarding Financial Results for the First Quarter of FYE 3/2023 July 15, 2022 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 99.92 KB) July 15, 2022 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 64.64 KB) View all Business Overview Introduction to the businesses operated by the Terumo Group /business Technology Introduction to Terumo's research and development activities and production system /technology
July 15, 2022 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Remuneration Plan (PDF 99.92 KB)
July 15, 2022 Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 64.64 KB)
